You searched for "atrophy"
Volunteers urged to consider VCHP in 2025
Chair of Vision Care for Homeless People (VCHP) Elaine Styles is urging the profession to get behind the charity in 2025 and put a few hours aside each month for volunteering. “We have ambitious plans for the growth of our...Blind West Lothian Man Set to Compete in National Futsal Final
A man from Armadale will compete in one of the UK’s top disability football events this month, after his team reached the final of the FA Disability Cup. Neil Atkinson (26) was diagnosed with Stargardt’s Disease at 17 – a...
How does low-concentration atropine reduce progression of myopia?
This is a double-blind, randomised, placebo-controlled trial evaluating the effects of low-concentration atropine (0.05%, 0.025%, 0.01%) on ocular biometrics of myopic children. The aim is to determine what aspect of ocular biometrics low-concentration atropine influenced in reducing the progression of...Clinical relevance of the anatomic classification of neovascular age-related macular degeneration
The author explains why an OCT-based classification of neovascular AMD is needed and how these neovascular subtypes may help to predict patients’ long-term visual outcome. Age-related macular degeneration (AMD) is a chronic and progressive neurodegenerative process involving the macula in...Microcatheter in the vertebral artery as a cause of branched retinal artery occlusion?
A 19-year-old male presented to eye casualty with a seven-day history of a ‘blurred patch’ in the left eye. The patient denied any other visual symptoms including flashes or floaters and there had been no change in visual symptoms in...Macular Society chief executive, Cathy Yelf, announces retirement
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.
Intravitreal aflibercept for retinal angiomatous proliferation (RAP)
In this prospective study the authors present the visual and anatomical outcome of patients with RAP lesions who were treated with intravitreal aflibercept. The study cohort of 46 patients reached study completion at week 96. They were all Caucasians, with...
Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report
Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...
